[Hematological control in the treatment of epilepsy].
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000927:Anticonvulsants / Q000009:adverse effects* / Q000494:pharmacology; D002648:Child; D004827:Epilepsy / Q000188:drug therapy*; D005260:Female; D005492:Folic Acid / Q000097:blood; D006402:Hematologic Diseases / Q000139:chemically induced*; D006413:Hematopoietic System / Q000187:drug effects; D006801:Humans; D006827:Hydantoins / Q000494:pharmacology; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D010634:Phenobarbital / Q000494:pharmacology; D011324:Primidone / Q000494:pharmacology
D000927:Anticonvulsants; D006827:Hydantoins; D011324:Primidone; D005492:Folic Acid; D010634:Phenobarbital
Kontrola hematologiczna w przebiegu leczenia padaczki.